Status:

UNKNOWN

Acute Physiological Responses to Twice Daily Blood Flow Restriction Training

Lead Sponsor:

Defence Medical Rehabilitation Centre, UK

Collaborating Sponsors:

University of Bath

Conditions:

Muscle Weakness

Muscle Damage

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

The Academic Department of Military Rehabilitation (ADMR) is currently conducting a pan-defence, randomised control trial (RCT) investigating the utility of twice daily blood flow restriction training...

Eligibility Criteria

Inclusion Criteria:

  • Age 18 - 55 years
  • Must not have performed regular lower-limb resistance training for the last 6 months (participants must have performed < 1 lower-limb resistance training session per week over the previous 6 months)
  • DMRC Staff member (civilian or service personnel)

Exclusion Criteria:

  • Any medical contraindication related to BFR*.

  • Any current lower-limb musculoskeletal injury

  • Restricted range of movement. i.e. Chronically locked knee or fixed flexion deformity.

  • Any physical impairment or co-morbidities (including cardio-vascular disease) precluding the safe participation in the intervention and/or assessment procedures

  • Non-musculoskeletal or serious pathological condition (i.e. Inflammatory arthropathy, infection or tumour).

  • Use of any medication which may contraindicate the performance of BFR or influence blood biomarkers of EIMD or inflammation.

  • Use of any performance enhancing supplements or ergogenic aids such as creatine monohydrate.

  • Any individual who is known to be currently pregnant

    *Medical-based Exclusion Criteria (based on clinical contraindications to performing BFR):

  • History of cardiovascular disease (hypertension, peripheral vascular disease, thrombosis/embolism, ischaemic heart disease, myocardial infarction).

  • History of the following musculoskeletal disorders: rheumatoid arthritis, avascular necrosis or osteonecrosis, severe osteoarthritis.

  • History of the following neurological disorders: Peripheral neuropathy, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, severe traumatic brain injury.

  • Varicose veins in the lower-limb.

  • Acute viral or bacterial upper or lower respiratory infection at screening.

  • Known or suspected lower limb chronic exertional compartment syndrome (tourniquet raises intra-compartmental muscle pressure).

  • Postsurgical swelling.

  • Surgical insertion of metal components at the position of cuff inflation.

  • History of any of the following conditions or disorders not previously listed: diabetes, active cancer.

  • History of elevated risk of unexplained fainting or dizzy spells during physical activity/exercise that causes loss of balance

  • Increased risk of haemorrhagic stroke, exercise induced rhabdomyolysis.

Key Trial Info

Start Date :

November 6 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2024

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT06334224

Start Date

November 6 2023

End Date

September 1 2024

Last Update

March 27 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Defence Medical Rehabilitation Centre

Loughborough, United Kingdom, LE12 5QW